Yestar Healthcare Holdings Company Limited provided earnings guidance for the six months ended 30 June 2021. The Group is expected to record an unaudited consolidated net profit of the Group of not less than RMB 115 million and an unaudited consolidated net profit attributable to the owners of the parent of not less than RMB 105 million for the six months ended 30 June 2021 as compared to an unaudited consolidated net loss of the Group of approximately RMB 702.8 million and an unaudited consolidated net loss attributable to the owners of the parent of approximately RMB6 40.3 million for the six months ended 30 June 2020.